Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totaling 40,000 shares, a growth of 42.3% from the September 30th total of 28,100 shares. Based on an average daily trading volume, of 432,300 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 432,300 shares, the days-to-cover ratio is presently 0.1 days.
Analyst Ratings Changes
Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Siemens Healthineers in a research report on Monday, October 6th. Three investment analysts have rated the stock with a Strong Buy rating and two have given a Buy rating to the company’s stock. According to data from MarketBeat.com, Siemens Healthineers has an average rating of “Strong Buy”.
Get Our Latest Report on Siemens Healthineers
Siemens Healthineers Stock Performance
Siemens Healthineers Company Profile
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Further Reading
- Five stocks we like better than Siemens Healthineers
- What Makes a Stock a Good Dividend Stock?
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- What does consumer price index measure?
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Uber Is Crushing Lyft—And It’s Not Even Close
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.
